Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.38
-0.09 (-1.20%)
Oct 6, 2026, 4:00 PM EDT - Market closed
Evolus Market Cap
Evolus has a market cap or net worth of $487.45 million as of October 6, 2026. Its market cap has increased by 15.92% in one year.
Market Cap
487.45M
Enterprise Value
607.09M
1-Year Change
15.92%
Ranking
Category
Stock Price
$7.38
ChartMarket Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $487.45M, an increase of 79.67%. That is a compound annual growth rate of 7.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 487.50M | 13.08% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 710.04M |
| Ironwood Pharmaceuticals | 596.52M |
| Evotec SE | 590.17M |
| Aquestive Therapeutics | 562.29M |
| Tilray Brands | 508.24M |
| Glass House Brands | 480.64M |
| Alpha Teknova | 476.21M |
| Kamada | 457.91M |